Melbourne Health
Clinical trials sponsored by Melbourne Health, explained in plain language.
-
New combo therapy may help preserve insulin-making cells in type 1 diabetes
Disease control CompletedThis study tested whether combining two immune therapies—abatacept (injected weekly) and nasal insulin (sprayed into the nose)—can help preserve the pancreas's ability to make insulin in people recently diagnosed with type 1 diabetes. 68 participants aged 6 to 21 took part for 48…
Phase: PHASE2 • Sponsor: Melbourne Health • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New brain tumor drug shows early promise in small study
Knowledge-focused CompletedThis study tested an experimental drug called AB-218 in 14 people with a specific type of slow-growing brain tumor (IDH1 mutated low-grade glioma) who were already scheduled for surgery. The main goals were to see if it's possible to run this kind of study and to measure how much…
Phase: EARLY_PHASE1 • Sponsor: Melbourne Health • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC